Vascular closure devices market seen reaching $2.31 billion by 2030

The Business Research Company says the vascular closure devices market will rise from $1.73 billion in 2026 to $2.31 billion by 2030, driven by more catheterization procedures, radial access techniques and demand for faster recovery. North America led in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Vascular closure devices are used to seal arterial access points after catheterization and help reduce bleeding, hematoma formation and other complications. - The market is tied to rising cardiovascular disease, obesity and broader demand for minimally invasive procedures that shorten recovery time and hospital stays. - Faster adoption could affect how hospitals manage access-site safety, patient mobilization and post-procedure care.

What happened: - The Business Research Company released a report on the global vascular closure devices market covering market size, trends and forecasts from 2026 to 2035. - The report puts the market at $1.62 billion in 2025 and $1.73 billion in 2026, implying 6.6% annual growth. - The same report forecasts the market will reach $2.31 billion by 2030, with growth accelerating to 7.6% annually. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing region during the forecast period.

The details: - The market’s near-term growth is supported by more cardiac catheterization and angioplasty procedures. - Hospitals are adopting suture-based and mechanical closure devices to cut manual compression time and speed recovery. - Growing awareness of post-procedural bleeding is also lifting adoption. - The report links future demand to wider use of radial access techniques in catheterization labs. - It also points to increasing use of external hemostatic devices and adjustable compression devices. - Emerging markets are expanding interventional cardiology capabilities and investing in better access-site safety. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report says its 2026 edition includes market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The report’s growth case suggests vascular closure devices are shifting from a procedural add-on to a standard part of efforts to reduce complications and discharge patients faster. - The focus on radial access and minimally invasive closure tools signals changing clinical practice, not just higher procedure volumes. - The obesity and cardiovascular disease trends point to sustained demand rather than a short-term spike. - The regional split suggests mature markets will keep driving revenue, while emerging markets add the fastest incremental growth.

What's next: - Demand is expected to keep rising as angiography and cardiology procedure volumes increase and clinicians prioritize faster hemostasis. - Market growth will likely track continued adoption of closure technologies that reduce bleeding risk and support shorter hospital stays. - The Business Research Company is offering a free sample and the full report online: Download the sample report and View the full market report. - The company also listed contact details for report inquiries through Saumya Sahay and Oliver Guirdham.

The bottom line: - Vascular closure devices are benefiting from more heart procedures, more minimally invasive care and a stronger push to reduce bleeding complications after intervention.